Belite Bio (BLTE) Other Non Operating Income (2024 - 2026)

Belite Bio's Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$13.2 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 97.84% year-over-year to -$13.2 million in Q1 2026; TTM through Mar 2026 was -$35.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$41000.0, down 129.08% from the prior year.
• Other Non Operating Income declined to -$13.2 million in Q1 2026 per BLTE's latest filing, from -$11.7 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at -$4.2 million in Q4 2024 and bottomed at -$13.2 million in Q1 2026.
• The 3-year median for Other Non Operating Income is -$9.2 million (2025), against an average of -$8.9 million.
• Across the five-year window, Other Non Operating Income plunged 178.53% in 2025 and sank 97.84% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at -$4.2 million in 2024, then plunged by 178.53% to -$11.7 million in 2025, then retreated by 12.64% to -$13.2 million in 2026.
• Per Business Quant, the three latest BLTE Other Non Operating Income figures stand at -$13.2 million (Q1 2026), -$11.7 million (Q4 2025), and -$6.7 million (Q1 2025).